Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 3, Pages E498-E505
Publisher
Proceedings of the National Academy of Sciences
Online
2018-01-03
DOI
10.1073/pnas.1715118115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype
- (2017) X Guo et al. ONCOGENE
- A novel anti-viral role for STAT3 in IFN-α signalling responses
- (2016) Rebecca Mahony et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Nuclear Import of JAK1 Is Mediated by a Classical NLS and Is Required for Survival of Diffuse Large B-cell Lymphoma
- (2016) Fen Zhu et al. MOLECULAR CANCER RESEARCH
- Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma
- (2016) Lixin Rui et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A mix of S and ΔS variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture
- (2016) M Zheng et al. Oncogenesis
- Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma
- (2015) John G. Gribben et al. JOURNAL OF CLINICAL ONCOLOGY
- Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
- (2015) Priscilla N. Kelly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma
- (2014) C. Y. Ok et al. CLINICAL CANCER RESEARCH
- Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
- (2014) Umberto Vitolo et al. LANCET ONCOLOGY
- IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
- (2013) HyeonJoo Cheon et al. EMBO JOURNAL
- Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2013) Xin Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- Large-scale gene function analysis with the PANTHER classification system
- (2013) Huaiyu Mi et al. Nature Protocols
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- STAT3 Targets Suggest Mechanisms of Aggressive Tumorigenesis in Diffuse Large B-Cell Lymphoma
- (2013) Jennifer Hardee et al. G3-Genes Genomes Genetics
- Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
- (2012) Yibin Yang et al. CANCER CELL
- Janus Kinase Deregulation in Leukemia and Lymphoma
- (2012) Edwin Chen et al. IMMUNITY
- Ruxolitinib
- (2012) Ruben A. Mesa et al. NATURE REVIEWS DRUG DISCOVERY
- STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
- (2011) A. Scuto et al. CANCER RESEARCH
- Malignant pirates of the immune system
- (2011) Lixin Rui et al. NATURE IMMUNOLOGY
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic Activation of NF- B
- (2010) L. M. Staudt Cold Spring Harbor Perspectives in Biology
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- MEME SUITE: tools for motif discovery and searching
- (2009) T. L. Bailey et al. NUCLEIC ACIDS RESEARCH
- Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- (2008) Peter H. Wiernik et al. JOURNAL OF CLINICAL ONCOLOGY
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started